Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Maarten Emmelot"'
Autor:
Henk Rozemuller, Ellen van der Spek, Lijnie H. Bogers-Boer, Mieke C. Zwart, Vivienne Verweij, Maarten Emmelot, Richard W. Groen, Robbert Spaapen, Andries C. Bloem, Henk M. Lokhorst, Tuna Mutis, Anton C. Martens
Publikováno v:
Haematologica, Vol 93, Iss 7 (2008)
Background The development and preclinical testing of novel immunotherapy strategies for multiple myeloma can benefit substantially from a humanized animal model that enables quantitative real-time monitoring of tumor progression. Here we have explor
Externí odkaz:
https://doaj.org/article/0158c728e41449cdb1e57dd90e374e46
Autor:
Ellen van der Spek, Laurens E. Franssen, Pieter Sonneveld, Laura M. Faber, Xiaozhong Qian, Ruud Doorn, Anjan Thakurta, Gerard M. J. Bos, Sonja Zweegman, Jeroen F. van Velzen, Henk M. Lokhorst, Hsiling Chiu, Saskia K. Klein, Berris van Kessel, Inger S. Nijhof, Harry R. Koene, Maarten Emmelot, Reinier Raymakers, Niels W.C.J. van de Donk, Tuna Mutis, Andries C. Bloem, Chad C. Bjorklund, Mark-David Levin, Annemiek Broijl, Aart Beeker
Publikováno v:
Oncotarget, 9(74), 34009-34021. Impact Journals
Franssen, L E, Nijhof, I S, Bjorklund, C C, Chiu, H, Doorn, R, Van Velzen, J, Emmelot, M, Van Kessel, B, Levin, M D, Bos, G M J, Broijl, A, Klein, S K, Koene, H R, Bloem, A C, Beeker, A, Faber, L M, Van Der Spek, E, Raymakers, R, Sonneveld, P, Zweegman, S, Lokhorst, H M, Thakurta, A, Qian, X, Mutis, T & Van De Donk, N W C J 2018, ' Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients ', Oncotarget, vol. 9, no. 74, pp. 34009-34021 .
Oncotarget
Oncotarget, 9(74), 34009-34021. Impact Journals LLC
Oncotarget, 9(74), 34009. Impact Journals
Franssen, L E, Nijhof, I S, Bjorklund, C C, Chiu, H, Doorn, R, Van Velzen, J, Emmelot, M, Van Kessel, B, Levin, M D, Bos, G M J, Broijl, A, Klein, S K, Koene, H R, Bloem, A C, Beeker, A, Faber, L M, Van Der Spek, E, Raymakers, R, Sonneveld, P, Zweegman, S, Lokhorst, H M, Thakurta, A, Qian, X, Mutis, T & Van De Donk, N W C J 2018, ' Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients ', Oncotarget, vol. 9, no. 74, pp. 34009-34021 .
Oncotarget
Oncotarget, 9(74), 34009-34021. Impact Journals LLC
Oncotarget, 9(74), 34009. Impact Journals
We recently showed that the outcome of multiple myeloma (MM) patients treated in the REPEAT study (evaluation of lenalidomide combined with low-dose cyclophosphamide and prednisone (REP) in lenalidomide-refractory MM) was markedly better than what ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4e05171aec04316e7150137f39e01b5
https://research.vumc.nl/en/publications/9952d8a0-3eca-4554-a20a-1f5c0b426190
https://research.vumc.nl/en/publications/9952d8a0-3eca-4554-a20a-1f5c0b426190
